← All organizations

Highest phase reached
Phase 2
First clinical trial
Sep 30, 2019Last known activity
Nov 19, 2023
Timeline
2010s
- Jan 1, 2016
NeuroSense Therapeutics Ltd.— Founded
Drugs by trial phase (2 distinct, 6 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06185543Lead sponsorPhase 2Nov 19, 2023
- NCT05436678Lead sponsorPhase 1Jul 26, 2022
- NCT05357950Lead sponsorPhase 2May 31, 2022
- NCT05232461Lead sponsorPhase 1Apr 8, 2022
- NCT04165850Lead sponsorPhase 2Nov 25, 2019
- NCT04090684Lead sponsorPhase 1Sep 30, 2019
Details
- Founded
- Herzeliya, IL Jan 1, 2016
- Last known activity
- Nov 19, 2023